How Does Cannabis Compare to Anticonvulsants in Treating Trigeminal Neuralgia?

PostedFebruary 22, 2026

UpdatedFebruary 22, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

For patients with trigeminal neuralgia, managing severe facial nerve pain can be challenging. Evaluating cannabis vs anticonvulsants helps patients and clinicians understand potential treatment options, weighing efficacy, tolerability, and safety.

Comparing Cannabis vs Anticonvulsants

Research comparing cannabis vs anticonvulsants is limited but growing. Insights from existing studies suggest that both approaches may offer relief, but differences in comparative efficacy, side effects, and treatment outcomes are important to consider.

Comparative Efficacy

While anticonvulsants are a standard therapy, some patients report meaningful pain relief from medical cannabis. Studies indicate that cannabis vs anticonvulsants may show similar efficacy in certain individuals, though responses can vary.

Side Effects

Anticonvulsants often carry side effects such as dizziness, fatigue, or cognitive changes. Cannabis may present a different side effects profile, including mild sedation or dry mouth, offering an alternative for those who are intolerant to traditional medications.

Treatment Outcomes

Treatment outcomes depend on individual patient response. Combining cannabis with standard anticonvulsants is being explored in some cases to optimise pain control while minimising adverse effects.

Individual Considerations

Choosing between cannabis vs anticonvulsants requires careful evaluation of patient history, comorbidities, and prior medication responses. Personalised treatment plans are key to effective trigeminal neuralgia management.

In summary, while anticonvulsants remain first-line therapy, cannabis vs anticonvulsants comparisons suggest potential benefits of cannabis for certain patients, particularly for those seeking alternative or adjunctive therapies. Clinical guidance and careful monitoring are essential for safe and effective use.

If you’re exploring cannabis treatment options for trigeminal neuralgia, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and trigeminal neuralgia.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.